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Pediatric ganglioneuroma, although benign, is typically treated by surgical resection. However, it is often
asymptomatic and an incidental ﬁnding. We present an incidental multifocal ganglioneuroma diagnosed
within the appendix and the subsequent treatment for this lesion. This intraoperative discovery led to
the diagnosis of PTEN (phosphatase and tensin homolog) hamartoma syndrome which had otherwise
gone undiagnosed.
 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Ganglioneuroma is a benign, well differentiated neoplasm
within the spectrum of neuroblastic tumors. These tumors arise
from neural crest cells and are characterized by mature ganglion
cells. The clinical presentation is varied and imaging is often useful
in characterizing the neoplasm [1]. Here we describe a case
of incidental multifocal ganglioneuroma discovered following
laparoscopic appendectomy and the subsequent postoperative
oncologic evaluation leading to the eventual diagnosis of PTEN
hamartoma tumor syndrome (PHTS).
1. Case report
Patient is a 13-year old female with a history of sickle cell trait,
asthma and Chiari malformation who presented with a 5 day
history of abdominal pain. The pain was initially diffuse and then
localized to the lower quadrants of the abdomen. The patient
reported nausea, vomiting and constipation. On physical exam, the
patient was non-tachycardic and afebrile. She had tenderness at
McBurney’s point and a positive Roving’s sign. White blood cellldren’s Mercy Hospital, 2401
6 234 3575; fax: þ1 816 983
rickson).
Inc. This is an open access article ucount was elevated at 15.2103/mL and anemiawith a hemoglobin
of 8.4 gm/dL. Abdominal ultrasound revealed a dilated, non-
compressible appendix measuring 10 mm in diameter. The bowel
wall appearance was normal.
She was taken to the operating room for laparoscopic appen-
dectomy for presumed appendicitis. An inﬂamed appendix was
visualized in the right lower quadrant (Fig. 1). The appendix was
mobilized and divided using an endoGIA stapler. The meso-
appendix was similarly divided and the specimen removed. She
was discharged uneventfully on postoperative day one.
Final pathology revealed multifocal ganglioneuroma with
microscopic nodular areas greater than 1.0 cm apart within the
appendix. The largest lesion was located near the tip, polypoid in
appearance, and measured 1.0  0.4  0.4 cm. The lesion was
conﬁned to the mucosa. Microscopic inspection displayed ganglion
cells with surrounding spindle and inﬂammatory cells. There were
no mitotic ﬁgures and the mucosal layer was intact (Fig. 2).
Synaptophysin stains were positive in the ganglion and spindle
cells. Due to the multifocal nature, further oncologic evaluationwas
recommended to rule out ganglioneuromatosis and other associ-
ated diseases.
On further history and exam, the patient was noted to have
macrocephaly, upper lid lipoma, a large lipoma of the sternoclei-
domastoid, a breast nodule, and skin ﬁndings consistent withnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Intraoperative evaluation.
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cancers including breast, uterine, and pancreatic, as well as possible
thyroid issues. Thus the patient was referred for genetic testing and
found to be heterozygous for a pathogenic variant in the PTEN gene,
consistent with a diagnosis of PTEN hamartoma tumor syndrome.
Due to the history of a Chiari malformation, a genome-wide
microarray was also performed that showed no other clinically
signiﬁcant variants.Fig. 2. Histologic examination of the mucosal ganglioneuroma; A) Displacement of
dilated crypts (2 magniﬁcation) B) Many ganglion cells (40 magniﬁcation).Further workup was initiated given the cancer predisposition
syndrome. Urine catecholamines, serum metanephrines, and
chromogranin A were within normal limits. Positron emission
tomography (PET), metaiodobenzylguanidine scan (MIBG), and
computed tomography of the neck, chest, abdomen and pelvis were
performed. There was persistent expected inﬂammation in the
postoperative region on PET scan, but this was not felt to represent
residual ganglioneuroma, and MIBG and CT scans were negative.
Thyroid ultrasound was normal. Urine catecholamines were done
every 3 months for 1-year, followed by every 6 months for 2 year.
Thyroid US and dermatology exams have been done yearly. Breast
nodules are followed every 6 months with US. There has been no
recurrence and no new symptoms corresponding to the patient’s
PHTS, and the patient is now 18 months from surgical resection.
2. Discussion
Peripheral neuroblastic tumors arise from neural crest cells, the
origin of the sympathetic nervous system. As they become increas-
ingly well differentiated, neuroblasts develop into neurons with
surrounding stromal component. Neuroblastoma and ganglioneuro-
blastoma are stroma poor in contrast to the stroma rich ganglio-
neuroma [2]. Ganglioneuromas may be isolated or occur in
conjunction with neuroﬁbromatosis type 1, Cowden syndrome or
PTENhamartoma tumor syndrome, andmultipleendocrineneoplasia
type 2B [3,4]. Those that arise spontaneously are typically located in
the mediastinum, retroperitoneum, colon and mesentery [5].
Ganglioneuroma has a good prognosis compared to its coun-
terparts. However, even with biopsy it can be difﬁcult to charac-
terize these neuroblastic tumors. Traditionally, the treatment
recommendation for ganglioneuroma is surgical excision. A large
French review suggested appendectomy alone was a sufﬁcient
intervention for incidentally identiﬁed ganglioneuroma within the
appendix (rather than hemicolectomy) [6]. However two retro-
spective reviews have challenged the necessity of any operative
intervention. In one series of 24 ganglioneuroma patients, four
were left with residual disease but had no recurrence after an
average of 84 months. There were also 6 patients with post-
operative complications including bowel obstruction, urinary
retention, scoliosis, and Horner’s syndrome [7]. A separate series of
24 ganglioneuroma patients found 30% had postoperative compli-
cations; again Horner’s and intestinal obstruction were included.
There were more complications for thoracic versus abdominal
resection. There was no evidence of tumor progression and no
mortality at follow up, average 33.5 months [8]. If surgical excision
of a suspected ganglioneuroma is pursued, consideration must be
given to intraoperative catecholamine release as there can be
tumoral hypersecretion. One recent case report highlighted unex-
pected hypertension during excision requiring intravenous stabili-
zation. It is unclear who requires preoperative alpha blockade at
this time and further studies are needed [9], however if patients
have symptoms suggestive of tumoral hypersecretion (episodic
headaches, hypertension, sweating, and tachycardia) then further
workup is crucial prior to operative procedures.
PTEN hamartoma syndrome has variable manifestations arising
from mutations in the PTEN gene, a tumor suppressor gene on
chromosome 10. Patients typically have multiple hamartomas
in more than one organ and an elevated malignancy risk [3]. In
patients with incidentally diagnosed ganglioneuroma as part of the
PTEN syndrome, colonoscopy should be performed as surveillance
beginning at age 35 due to the increased risk for colorectal cancer
[3]. Some authors propose additional surveillance of the thyroid,
uterus and breast due to the associationwith these syndromes [10].
Because of our patient’s family history, she continues with yearly
thyroid ultrasounds, and every 6 month breast ultrasounds.
K.W. Gonzalez et al. / J Ped Surg Case Reports 11 (2016) 22e24243. Conclusion
Current recommendations for the treatment of appendiceal
ganglioneuromas include surgical excision. However, consideration
must be given for postoperative complications particularly in pe-
diatric patients. PET scan may be useful to help assess the burden of
disease peri-operatively. Thorough family history and clinical exam
are imperative to ruling out cancer predisposition syndromes that
may present with intestinal ganglioneuromas.
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